Announced

ESTEVE to acquire Regis Technologies.

Synopsis

ESTEVE, a pharmaceutical company, agreed to acquire Regis Technologies, a contract development and manufacturing organization. Financial terms were not disclosed. "We are proud to announce that we are increasing our team, and our CDMO solutions for pharmaceutical innovators: this acquisition is adding capabilities, as well as development and manufacturing capacity, while increasing the team of ESTEVE's CDMO business with around 70 skilled people", Joan Petit, ESTEVE Chief Industrial Operations Officer.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite